ONTOLOGY REPORT - ANNOTATIONS
| Term: | carotene |
|
| Accession: | CHEBI:23042
|
browse the term
|
| Definition: | Hydrocarbon carotenoids. |
| Synonyms: | related_synonym: | carotenes |
|
|
8'-apo-beta,psi-caroten-8'-al
|
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
increases expression |
ISO |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
increases expression |
ISO |
2 |
235,979,108 |
235,991,515 |
RGD:6480464 |
CTD |
| G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
|
decreases expression |
ISO |
5 |
62,311,268 |
62,316,276 |
RGD:6480464 |
CTD |
| G |
Aldh3b1 |
aldehyde dehydrogenase 3 family, member B1 |
|
decreases expression |
ISO |
1 |
206,438,325 |
206,455,477 |
RGD:6480464 |
CTD |
| G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
|
decreases expression |
ISO |
5 |
158,437,691 |
158,453,827 |
RGD:6480464 |
CTD |
| G |
Ank2 |
ankyrin 2, neuronal |
|
increases expression |
ISO |
2 |
224,182,431 |
224,501,751 |
RGD:6480464 |
CTD |
| G |
Ank3 |
ankyrin 3, node of Ranvier (ankyrin G) |
|
increases expression |
ISO |
20 |
19,328,684 |
19,828,196 |
RGD:6480464 |
CTD |
| G |
Asah1 |
N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
|
increases expression |
ISO |
16 |
54,279,253 |
54,311,084 |
RGD:6480464 |
CTD |
| G |
Asb1 |
ankyrin repeat and SOCS box-containing 1 |
|
increases expression |
ISO |
9 |
90,758,693 |
90,774,541 |
RGD:6480464 |
CTD |
| G |
Asb9 |
ankyrin repeat and SOCS box-containing 9 |
|
increases expression |
ISO |
X |
50,712,265 |
50,748,863 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
decreases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
multiple interactions |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Casp8ap2 |
caspase 8 associated protein 2 |
|
increases expression |
ISO |
5 |
48,920,175 |
48,958,139 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cldn10 |
claudin 10 |
|
increases expression |
ISO |
15 |
103,699,243 |
103,793,405 |
RGD:6480464 |
CTD |
| G |
Cldn18 |
claudin 18 |
|
increases expression |
ISO |
8 |
104,560,892 |
104,578,313 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
decreases expression |
ISO |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Col4a2 |
collagen, type IV, alpha 2 |
|
decreases expression |
ISO |
16 |
82,899,206 |
83,045,102 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
decreases expression |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
decreases expression |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
increases expression |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
increases expression |
ISO |
14 |
17,284,085 |
17,288,996 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases expression |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Dlx2 |
distal-less homeobox 2 |
|
increases expression |
ISO |
3 |
53,852,209 |
53,854,092 |
RGD:6480464 |
CTD |
| G |
Dlx4 |
distal-less homeobox 4 |
|
increases expression |
ISO |
10 |
83,822,815 |
83,828,210 |
RGD:6480464 |
CTD |
| G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ets1 |
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
|
decreases expression |
ISO |
8 |
32,481,694 |
32,545,237 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
increases expression |
ISO |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gbp1 |
guanylate binding protein 1, interferon-inducible |
|
increases expression |
ISO |
2 |
240,715,506 |
240,739,741 |
RGD:6480464 |
CTD |
| G |
Gstk1 |
glutathione S-transferase kappa 1 |
|
decreases expression |
ISO |
4 |
69,999,767 |
70,004,086 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
decreases expression |
ISO |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm4 |
glutathione S-transferase mu 4 |
|
decreases expression |
ISO |
2 |
203,605,593 |
203,610,817 |
RGD:6480464 |
CTD |
| G |
Gstz1 |
glutathione S-transferase zeta 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hoxa7 |
homeobox A7 |
|
increases expression |
ISO |
4 |
80,515,622 |
80,517,521 |
RGD:6480464 |
CTD |
| G |
Hoxb6 |
homeo box B6 |
|
increases expression |
ISO |
10 |
85,030,558 |
85,033,604 |
RGD:6480464 |
CTD |
| G |
Hoxc10 |
homeo box C10 |
|
increases expression |
ISO |
7 |
141,717,910 |
141,734,613 |
RGD:6480464 |
CTD |
| G |
Ifna16l1 |
interferon, alpha 16-like 1 |
|
increases expression |
ISO |
5 |
108,070,121 |
108,070,696 |
RGD:6480464 |
CTD |
| G |
Irf8 |
interferon regulatory factor 8 |
|
increases expression |
ISO |
19 |
51,100,088 |
51,116,730 |
RGD:6480464 |
CTD |
| G |
Irx4 |
iroquois homeobox 4 |
|
decreases expression |
ISO |
17 |
106,225 |
116,183 |
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
decreases expression |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
increases expression |
ISO |
2 |
185,556,271 |
185,558,310 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
decreases expression |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt2 |
keratin 2 |
|
increases expression |
ISO |
7 |
140,500,902 |
140,507,590 |
RGD:6480464 |
CTD |
| G |
Krt7 |
keratin 7 |
|
affects expression |
ISO |
7 |
140,160,829 |
140,226,474 |
RGD:6480464 |
CTD |
| G |
Lhx3 |
LIM homeobox 3 |
|
increases expression |
ISO |
3 |
4,381,890 |
4,389,132 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Meis2 |
Meis homeobox 2 |
|
increases expression |
ISO |
3 |
101,915,966 |
102,117,215 |
RGD:6480464 |
CTD |
| G |
Meox1 |
mesenchyme homeobox 1 |
|
increases expression |
ISO |
10 |
90,921,589 |
90,942,298 |
RGD:6480464 |
CTD |
| G |
Msh5 |
mutS homolog 5 (E. coli) |
|
increases expression |
ISO |
20 |
3,845,731 |
3,862,011 |
RGD:6480464 |
CTD |
| G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Olr1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
|
increases expression |
ISO |
4 |
166,747,228 |
166,769,340 |
RGD:6480464 |
CTD |
| G |
Pcdhgc3 |
protocadherin gamma subfamily C, 3 |
|
increases expression |
ISO |
18 |
30,714,544 |
30,754,205 |
RGD:6480464 |
CTD |
| G |
Plscr1 |
phospholipid scramblase 1 |
|
increases expression |
ISO |
8 |
97,206,388 |
97,226,725 |
RGD:6480464 |
CTD |
| G |
Plscr3 |
phospholipid scramblase 3 |
|
increases expression |
ISO |
10 |
56,687,086 |
56,691,601 |
RGD:6480464 |
CTD |
| G |
Plscr4 |
phospholipid scramblase 4 |
|
increases expression |
ISO |
8 |
97,428,403 |
97,466,096 |
RGD:6480464 |
CTD |
| G |
Rad51ap1 |
RAD51 associated protein 1 |
|
increases expression |
ISO |
4 |
163,308,788 |
163,321,854 |
RGD:6480464 |
CTD |
| G |
Rad51d |
RAD51 homolog D (S. cerevisiae) |
|
increases expression |
ISO |
10 |
71,092,798 |
71,107,418 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
decreases expression |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rarres1 |
retinoic acid receptor responder (tazarotene induced) 1 |
|
increases expression |
ISO |
2 |
157,332,213 |
157,367,137 |
RGD:6480464 |
CTD |
| G |
Six6 |
SIX homeobox 6 |
|
increases expression |
ISO |
6 |
95,358,546 |
95,363,526 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sptlc2 |
serine palmitoyltransferase, long chain base subunit 2 |
|
affects expression |
ISO |
6 |
111,546,037 |
111,622,959 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Tgm4 |
transglutaminase 4 (prostate) |
|
increases expression |
ISO |
8 |
127,782,460 |
127,819,491 |
RGD:6480464 |
CTD |
| G |
Tnfrsf9 |
tumor necrosis factor receptor superfamily, member 9 |
|
increases expression |
ISO |
5 |
168,071,159 |
168,099,501 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Txndc9 |
thioredoxin domain containing 9 |
|
increases expression |
ISO |
9 |
36,926,559 |
36,936,470 |
RGD:6480464 |
CTD |
| G |
Xrcc3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
|
increases expression |
ISO |
6 |
136,594,276 |
136,602,069 |
RGD:6480464 |
CTD |
9'-cis-neoxanthin
|
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
affects localization |
ISO |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
all-trans-neoxanthin
|
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
affects localization |
ISO |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
all-trans-phytoene
|
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
all-trans-phytofluene
|
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
alpha-carotene
|
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
affects response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
astaxanthin
|
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
multiple interactions |
ISO |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
C1qa |
complement component 1, q subcomponent, A chain |
|
decreases expression |
ISO |
5 |
155,662,333 |
155,665,180 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cntd1 |
cyclin N-terminal domain containing 1 |
|
multiple interactions |
ISO |
10 |
90,308,109 |
90,316,974 |
RGD:6480464 |
CTD |
| G |
Cox15 |
cytochrome c oxidase assembly homolog 15 (yeast) |
|
multiple interactions |
ISO |
1 |
247,077,102 |
247,093,757 |
RGD:6480464 |
CTD |
| G |
Cox5a |
cytochrome c oxidase, subunit Va |
|
multiple interactions |
ISO |
8 |
61,264,971 |
61,276,380 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
multiple interactions |
ISO |
9 |
35,625,478 |
35,627,304 |
RGD:6480464 |
CTD |
| G |
Cox6b1 |
cytochrome c oxidase subunit VIb polypeptide 1 |
|
multiple interactions |
ISO |
1 |
85,669,891 |
85,677,195 |
RGD:6480464 |
CTD |
| G |
Cox6c |
cytochrome c oxidase, subunit VIc |
|
multiple interactions |
ISO |
7 |
71,465,790 |
71,478,524 |
RGD:6480464 |
CTD |
| G |
Ctss |
cathepsin S |
|
decreases expression |
ISO |
2 |
190,425,290 |
190,466,877 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
multiple interactions |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gna13 |
guanine nucleotide binding protein (G protein), alpha 13 |
|
multiple interactions |
ISO |
10 |
98,933,205 |
98,965,819 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
multiple interactions |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Grn |
granulin |
|
multiple interactions |
ISO |
10 |
91,536,135 |
91,542,239 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hoxa7 |
homeobox A7 |
|
multiple interactions |
ISO |
4 |
80,515,622 |
80,517,521 |
RGD:6480464 |
CTD |
| G |
Hoxa9 |
homeobox A9 |
|
multiple interactions |
ISO |
4 |
80,524,246 |
80,526,491 |
RGD:6480464 |
CTD |
| G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
multiple interactions |
ISO |
9 |
63,769,401 |
63,790,622 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
multiple interactions |
ISO |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Mt-nd6 |
mitochondrially encoded NADH dehydrogenase 6 |
|
multiple interactions |
ISO |
MT |
13,543 |
14,061 |
RGD:6480464 |
CTD |
| G |
Ndufa1 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1 |
|
multiple interactions |
ISO |
X |
7,726,163 |
7,730,110 |
RGD:6480464 |
CTD |
| G |
Ndufa5 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5 |
|
multiple interactions |
ISO |
4 |
50,649,500 |
50,657,858 |
RGD:6480464 |
CTD |
| G |
Ndufc2 |
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2 |
|
multiple interactions |
ISO |
1 |
154,635,889 |
154,642,112 |
RGD:6480464 |
CTD |
| G |
Ndufv2 |
NADH dehydrogenase (ubiquinone) flavoprotein 2 |
|
multiple interactions |
ISO |
9 |
104,852,714 |
104,873,325 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
multiple interactions |
ISO |
10 |
82,582,766 |
82,588,269 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Pah |
phenylalanine hydroxylase |
|
decreases expression |
ISO |
7 |
24,175,898 |
24,243,592 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
EXP |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
decreases activity |
EXP |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Ppp1cb |
protein phosphatase 1, catalytic subunit, beta isozyme |
|
multiple interactions |
ISO |
6 |
24,067,544 |
24,099,280 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
multiple interactions |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
multiple interactions |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
multiple interactions |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Rps2 |
ribosomal protein S2 |
|
multiple interactions |
ISO |
10 |
13,975,350 |
13,977,199 |
RGD:6480464 |
CTD |
| G |
Skap2 |
src kinase associated phosphoprotein 2 |
|
decreases expression |
ISO |
4 |
80,149,846 |
80,300,111 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
multiple interactions |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tkt |
transketolase |
|
multiple interactions |
ISO |
16 |
5,908,759 |
5,933,695 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Ubb |
ubiquitin B |
|
multiple interactions |
ISO |
10 |
139,578,694 |
139,579,068 |
RGD:6480464 |
CTD |
| G |
Uqcrb |
ubiquinol-cytochrome c reductase binding protein |
|
multiple interactions |
ISO |
7 |
67,958,363 |
67,963,730 |
RGD:6480464 |
CTD |
| G |
Uqcrb-ps1 |
ubiquinol-cytochrome c reductase binding protein, pseudogene 1 |
|
multiple interactions |
ISO |
1 |
90,807,565 |
90,807,900 |
RGD:6480464 |
CTD |
| G |
Uqcrc2 |
ubiquinol cytochrome c reductase core protein 2 |
|
multiple interactions |
ISO |
1 |
179,459,817 |
179,490,381 |
RGD:6480464 |
CTD |
beta-carotene
|
| G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
increases expression |
ISO |
2 |
235,979,108 |
235,991,515 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
decreases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Aldh3b1 |
aldehyde dehydrogenase 3 family, member B1 |
|
decreases expression |
ISO |
1 |
206,438,325 |
206,455,477 |
RGD:6480464 |
CTD |
| G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
|
decreases expression |
ISO |
5 |
158,437,691 |
158,453,827 |
RGD:6480464 |
CTD |
| G |
Ank2 |
ankyrin 2, neuronal |
|
increases expression |
ISO |
2 |
224,182,431 |
224,501,751 |
RGD:6480464 |
CTD |
| G |
Ank3 |
ankyrin 3, node of Ranvier (ankyrin G) |
|
increases expression |
ISO |
20 |
19,328,684 |
19,828,196 |
RGD:6480464 |
CTD |
| G |
Asah1 |
N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
|
increases expression |
ISO |
16 |
54,279,253 |
54,311,084 |
RGD:6480464 |
CTD |
| G |
Asb1 |
ankyrin repeat and SOCS box-containing 1 |
|
increases expression |
ISO |
9 |
90,758,693 |
90,774,541 |
RGD:6480464 |
CTD |
| G |
Asb9 |
ankyrin repeat and SOCS box-containing 9 |
|
increases expression |
ISO |
X |
50,712,265 |
50,748,863 |
RGD:6480464 |
CTD |
| G |
Bag3 |
Bcl2-associated athanogene 3 |
|
decreases expression |
ISO |
1 |
187,781,147 |
187,804,835 |
RGD:6480464 |
CTD |
| G |
Bag4 |
BCL2-associated athanogene 4 |
|
decreases expression |
ISO |
16 |
70,663,821 |
70,680,671 |
RGD:6480464 |
CTD |
| G |
Bag5 |
BCL2-associated athanogene 5 |
|
decreases expression |
ISO |
6 |
136,491,438 |
136,495,093 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
decreases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcmo1 |
beta-carotene 15,15'-monooxygenase 1 |
|
multiple interactions |
ISO |
19 |
47,202,955 |
47,239,225 |
RGD:6480464 |
CTD |
| G |
Bcmo1 |
beta-carotene 15,15'-monooxygenase 1 |
|
multiple interactions |
EXP |
19 |
47,202,955 |
47,239,225 |
RGD:6480464 |
CTD |
| G |
Bcmo1 |
beta-carotene 15,15'-monooxygenase 1 |
|
increases expression |
ISO |
19 |
47,202,955 |
47,239,225 |
RGD:6480464 |
CTD |
| G |
Bcmo1 |
beta-carotene 15,15'-monooxygenase 1 |
|
increases oxidation |
EXP |
19 |
47,202,955 |
47,239,225 |
RGD:6480464 |
CTD |
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
multiple interactions |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
increases metabolic processing |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
1 |
87,626,111 |
87,627,499 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
increases expression |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cldn10 |
claudin 10 |
|
increases expression |
ISO |
15 |
103,699,243 |
103,793,405 |
RGD:6480464 |
CTD |
| G |
Cldn18 |
claudin 18 |
|
increases expression |
ISO |
8 |
104,560,892 |
104,578,313 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
decreases expression |
ISO |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Col4a2 |
collagen, type IV, alpha 2 |
|
decreases expression |
ISO |
16 |
82,899,206 |
83,045,102 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
decreases expression |
ISO |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Cradd |
CASP2 and RIPK1 domain containing adaptor with death domain |
|
increases expression |
ISO |
7 |
32,504,279 |
32,517,581 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
decreases expression |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
increases expression |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
increases expression |
ISO |
14 |
17,284,085 |
17,288,996 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
241,945,472 |
241,949,220 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases expression |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Dlx2 |
distal-less homeobox 2 |
|
increases expression |
ISO |
3 |
53,852,209 |
53,854,092 |
RGD:6480464 |
CTD |
| G |
Dlx4 |
distal-less homeobox 4 |
|
increases expression |
ISO |
10 |
83,822,815 |
83,828,210 |
RGD:6480464 |
CTD |
| G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
decreases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
|
increases expression |
ISO |
7 |
138,246,372 |
138,272,190 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas cell surface death receptor |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Foxa1 |
forkhead box A1 |
|
increases expression |
ISO |
6 |
77,976,384 |
78,009,176 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
increases expression |
ISO |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gbp1 |
guanylate binding protein 1, interferon-inducible |
|
increases expression |
ISO |
2 |
240,715,506 |
240,739,741 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
multiple interactions |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gstk1 |
glutathione S-transferase kappa 1 |
|
decreases expression |
ISO |
4 |
69,999,767 |
70,004,086 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
increases expression |
ISO |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm4 |
glutathione S-transferase mu 4 |
|
decreases expression |
ISO |
2 |
203,605,593 |
203,610,817 |
RGD:6480464 |
CTD |
| G |
Gstz1 |
glutathione S-transferase zeta 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hoxa7 |
homeobox A7 |
|
increases expression |
ISO |
4 |
80,515,622 |
80,517,521 |
RGD:6480464 |
CTD |
| G |
Hoxb6 |
homeo box B6 |
|
increases expression |
ISO |
10 |
85,030,558 |
85,033,604 |
RGD:6480464 |
CTD |
| G |
Hoxc10 |
homeo box C10 |
|
increases expression |
ISO |
7 |
141,717,910 |
141,734,613 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
multiple interactions |
EXP |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Ifna16l1 |
interferon, alpha 16-like 1 |
|
increases expression |
ISO |
5 |
108,070,121 |
108,070,696 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Irf8 |
interferon regulatory factor 8 |
|
increases expression |
ISO |
19 |
51,100,088 |
51,116,730 |
RGD:6480464 |
CTD |
| G |
Irx4 |
iroquois homeobox 4 |
|
decreases expression |
ISO |
17 |
106,225 |
116,183 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
decreases expression |
ISO |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
decreases expression |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
increases expression |
ISO |
2 |
185,556,271 |
185,558,310 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
increases expression |
ISO |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt2 |
keratin 2 |
|
increases expression |
ISO |
7 |
140,500,902 |
140,507,590 |
RGD:6480464 |
CTD |
| G |
Krt7 |
keratin 7 |
|
affects expression |
ISO |
7 |
140,160,829 |
140,226,474 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
decreases expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Lhx3 |
LIM homeobox 3 |
|
increases expression |
ISO |
3 |
4,381,890 |
4,389,132 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
decreases expression |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
multiple interactions |
ISO |
1 |
233,978,931 |
233,983,824 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Meis2 |
Meis homeobox 2 |
|
increases expression |
ISO |
3 |
101,915,966 |
102,117,215 |
RGD:6480464 |
CTD |
| G |
Meox1 |
mesenchyme homeobox 1 |
|
increases expression |
ISO |
10 |
90,921,589 |
90,942,298 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
affects response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Msh5 |
mutS homolog 5 (E. coli) |
|
increases expression |
ISO |
20 |
3,845,731 |
3,862,011 |
RGD:6480464 |
CTD |
| G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Olr1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
|
increases expression |
ISO |
4 |
166,747,228 |
166,769,340 |
RGD:6480464 |
CTD |
| G |
Pcdhgc3 |
protocadherin gamma subfamily C, 3 |
|
increases expression |
ISO |
18 |
30,714,544 |
30,754,205 |
RGD:6480464 |
CTD |
| G |
Pik3r5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
|
increases expression |
ISO |
10 |
55,227,872 |
55,248,301 |
RGD:6480464 |
CTD |
| G |
Plscr1 |
phospholipid scramblase 1 |
|
increases expression |
ISO |
8 |
97,206,388 |
97,226,725 |
RGD:6480464 |
CTD |
| G |
Plscr3 |
phospholipid scramblase 3 |
|
increases expression |
ISO |
10 |
56,687,086 |
56,691,601 |
RGD:6480464 |
CTD |
| G |
Plscr4 |
phospholipid scramblase 4 |
|
increases expression |
ISO |
8 |
97,428,403 |
97,466,096 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
decreases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Rad51ap1 |
RAD51 associated protein 1 |
|
decreases expression |
ISO |
4 |
163,308,788 |
163,321,854 |
RGD:6480464 |
CTD |
| G |
Rad51d |
RAD51 homolog D (S. cerevisiae) |
|
increases expression |
ISO |
10 |
71,092,798 |
71,107,418 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
decreases expression |
ISO |
10 |
87,740,479 |
87,753,265 |
RGD:6480464 |
CTD |
| G |
Rarb |
retinoic acid receptor, beta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rarres1 |
retinoic acid receptor responder (tazarotene induced) 1 |
|
increases expression |
ISO |
2 |
157,332,213 |
157,367,137 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
multiple interactions |
ISO |
1 |
242,443,795 |
242,450,997 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
multiple interactions |
ISO |
1 |
242,443,795 |
242,450,997 |
RGD:6480464 |
CTD |
| G |
Rxra |
retinoid X receptor alpha |
|
multiple interactions |
ISO |
3 |
6,605,782 |
6,689,224 |
RGD:6480464 |
CTD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
increases transport |
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:6480464 |
CTD |
| G |
Six6 |
SIX homeobox 6 |
|
increases expression |
ISO |
6 |
95,358,546 |
95,363,526 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
decreases expression |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sptlc2 |
serine palmitoyltransferase, long chain base subunit 2 |
|
affects expression |
ISO |
6 |
111,546,037 |
111,622,959 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
increases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
increases expression |
ISO |
3 |
148,832,866 |
148,862,385 |
RGD:6480464 |
CTD |
| G |
Tgm4 |
transglutaminase 4 (prostate) |
|
increases expression |
ISO |
8 |
127,782,460 |
127,819,491 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf9 |
tumor necrosis factor receptor superfamily, member 9 |
|
increases expression |
ISO |
5 |
168,071,159 |
168,099,501 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Txndc9 |
thioredoxin domain containing 9 |
|
increases expression |
ISO |
9 |
36,926,559 |
36,936,470 |
RGD:6480464 |
CTD |
| G |
Xrcc3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
|
increases expression |
ISO |
6 |
136,594,276 |
136,602,069 |
RGD:6480464 |
CTD |
beta-cryptoxanthin
|
| G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
multiple interactions |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
increases metabolic processing |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
ISO |
2 |
203,292,765 |
203,307,968 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
multiple interactions |
ISO |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Nfatc1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
|
multiple interactions |
ISO |
18 |
77,498,654 |
77,581,231 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
multiple interactions |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt-related transcription factor 2 |
|
increases expression |
ISO |
9 |
11,869,234 |
12,025,219 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
15 |
59,397,837 |
59,428,014 |
RGD:6480464 |
CTD |
canthaxanthin
|
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
carotenoid
|
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
decreases metabolic processing |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
multiple interactions |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects response to substance |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
affects response to substance |
ISO |
16 |
23,845,894 |
23,876,528 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects response to substance |
ISO |
16 |
23,855,555 |
23,876,531 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Rarg |
retinoic acid receptor, gamma |
|
increases expression |
ISO |
7 |
140,991,447 |
141,014,108 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
crocetin
|
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
EXP |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
fucoxanthin
|
| G |
Acox1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
ISO |
10 |
106,281,977 |
106,319,382 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases cleavage |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
increases expression |
ISO |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
decreases activity |
ISO |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
decreases expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Retn |
resistin |
|
decreases expression |
ISO |
12 |
2,499,630 |
2,501,370 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
lutein
|
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
increases metabolic processing |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
affects metabolic processing |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
multiple interactions |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
decreases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
lycopene
|
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Add1 |
adducin 1 (alpha) |
|
decreases expression |
ISO |
14 |
81,750,430 |
81,808,919 |
RGD:6480464 |
CTD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
multiple interactions |
ISO |
20 |
4,250,613 |
4,253,540 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
decreases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Andpro |
androgen regulated protein |
|
decreases expression |
EXP |
3 |
138,085,660 |
138,092,024 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
|
increases expression |
ISO |
11 |
27,467,207 |
27,500,173 |
RGD:6480464 |
CTD |
| G |
Bap1 |
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) |
|
increases expression |
ISO |
16 |
6,684,470 |
6,693,296 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcmo1 |
beta-carotene 15,15'-monooxygenase 1 |
|
multiple interactions |
ISO |
19 |
47,202,955 |
47,239,225 |
RGD:6480464 |
CTD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
decreases expression |
ISO |
4 |
67,117,759 |
67,243,058 |
RGD:6480464 |
CTD |
| G |
C1qa |
complement component 1, q subcomponent, A chain |
|
decreases expression |
ISO |
5 |
155,662,333 |
155,665,180 |
RGD:6480464 |
CTD |
| G |
C4b |
complement component 4B (Chido blood group) |
|
decreases expression |
ISO |
20 |
4,300,687 |
4,315,882 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
decreases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
decreases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
ISO |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk5 |
cyclin-dependent kinase 5 |
|
decreases expression |
ISO |
4 |
6,119,704 |
6,124,186 |
RGD:6480464 |
CTD |
| G |
Cdk7 |
cyclin-dependent kinase 7 |
|
decreases expression |
ISO |
2 |
31,500,629 |
31,525,590 |
RGD:6480464 |
CTD |
| G |
Cdk9 |
cyclin-dependent kinase 9 |
|
decreases expression |
ISO |
3 |
11,672,861 |
11,677,709 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Chga |
chromogranin A (parathyroid secretory protein 1) |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Chgb |
chromogranin B (secretogranin 1) |
|
decreases expression |
ISO |
3 |
120,571,736 |
120,584,874 |
RGD:6480464 |
CTD |
| G |
Crb1 |
crumbs homolog 1 (Drosophila) |
|
decreases expression |
ISO |
13 |
52,558,317 |
52,725,099 |
RGD:6480464 |
CTD |
| G |
Ctss |
cathepsin S |
|
decreases expression |
ISO |
2 |
190,425,290 |
190,466,877 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
decreases expression |
ISO |
17 |
14,286,747 |
14,295,502 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
decreases activity |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp21a1 |
cytochrome P450, family 21, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
20 |
4,125,357 |
4,128,518 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Ddb2 |
damage specific DNA binding protein 2 |
|
increases expression |
ISO |
3 |
75,568,487 |
75,591,428 |
RGD:6480464 |
CTD |
| G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma, 1 |
|
increases expression |
ISO |
11 |
82,451,555 |
82,471,735 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Fancc |
Fanconi anemia, complementation group C |
|
decreases expression |
ISO |
17 |
7,254,528 |
7,341,500 |
RGD:6480464 |
CTD |
| G |
Fancf |
Fanconi anemia, complementation group F |
|
decreases expression |
ISO |
1 |
101,664,895 |
101,666,720 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
decreases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja4 |
gap junction protein, alpha 4 |
|
decreases expression |
ISO |
5 |
146,755,061 |
146,757,594 |
RGD:6480464 |
CTD |
| G |
Gja5 |
gap junction protein, alpha 5 |
|
decreases expression |
ISO |
2 |
191,824,118 |
191,843,867 |
RGD:6480464 |
CTD |
| G |
Gja5 |
gap junction protein, alpha 5 |
|
increases expression |
ISO |
2 |
191,824,118 |
191,843,867 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
decreases expression |
ISO |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
multiple interactions |
EXP |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
decreases expression |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
increases expression |
ISO |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
decreases expression |
ISO |
2 |
185,556,271 |
185,558,310 |
RGD:6480464 |
CTD |
| G |
Jak1 |
Janus kinase 1 |
|
increases expression |
ISO |
5 |
121,804,586 |
121,905,581 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kif2a |
kinesin heavy chain member 2A |
|
increases expression |
ISO |
2 |
38,079,564 |
38,143,398 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin alpha 2 |
|
increases expression |
ISO |
10 |
96,342,214 |
96,352,613 |
RGD:6480464 |
CTD |
| G |
Ldlr |
low density lipoprotein receptor |
|
increases expression |
ISO |
8 |
20,824,040 |
20,846,920 |
RGD:6480464 |
CTD |
| G |
Lipa |
lipase A, lysosomal acid, cholesterol esterase |
|
increases expression |
ISO |
1 |
238,466,493 |
238,500,195 |
RGD:6480464 |
CTD |
| G |
LOC100359600 |
karyopherin alpha 2-like |
|
increases expression |
ISO |
6 |
10,523,393 |
10,524,982 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
increases expression |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
decreases expression |
ISO |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
decreases expression |
ISO |
10 |
52,009,149 |
52,041,599 |
RGD:6480464 |
CTD |
| G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
decreases expression |
ISO |
10 |
99,859,684 |
99,974,446 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
decreases expression |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases expression |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases expression |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
decreases expression |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mgat2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
increases expression |
ISO |
6 |
91,137,262 |
91,139,751 |
RGD:6480464 |
CTD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
increases expression |
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
increases expression |
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:6480464 |
CTD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
increases expression |
ISO |
6 |
11,525,292 |
11,542,592 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
decreases expression |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nup214 |
nucleoporin 214 |
|
decreases expression |
ISO |
3 |
11,079,165 |
11,165,173 |
RGD:6480464 |
CTD |
| G |
P22k15 |
cystatin related protein 2 |
|
decreases expression |
EXP |
3 |
138,329,673 |
138,336,731 |
RGD:6480464 |
CTD |
| G |
Pah |
phenylalanine hydroxylase |
|
decreases expression |
ISO |
7 |
24,175,898 |
24,243,592 |
RGD:6480464 |
CTD |
| G |
Pbsn |
probasin |
|
decreases expression |
EXP |
X |
63,581,742 |
63,597,497 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pla2g2a |
phospholipase A2, group IIA (platelets, synovial fluid) |
|
multiple interactions |
ISO |
5 |
157,654,786 |
157,657,360 |
RGD:6480464 |
CTD |
| G |
Prkdc |
protein kinase, DNA activated, catalytic polypeptide |
|
decreases expression |
ISO |
11 |
86,951,420 |
87,169,229 |
RGD:6480464 |
CTD |
| G |
Psbpc2 |
prostatic steroid-binding protein C2 |
|
decreases expression |
EXP |
1 |
212,121,766 |
212,124,641 |
RGD:6480464 |
CTD |
| G |
Rad50 |
RAD50 homolog (S. cerevisiae) |
|
increases expression |
ISO |
10 |
39,112,733 |
39,164,694 |
RGD:6480464 |
CTD |
| G |
Rassf7 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
|
increases expression |
ISO |
1 |
201,411,162 |
201,413,083 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases phosphorylation |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rdx |
radixin |
|
decreases expression |
ISO |
8 |
55,404,000 |
55,450,183 |
RGD:6480464 |
CTD |
| G |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
|
decreases expression |
ISO |
5 |
151,274,666 |
151,288,007 |
RGD:6480464 |
CTD |
| G |
Rps6ka3 |
ribosomal protein S6 kinase polypeptide 3 |
|
decreases expression |
ISO |
X |
56,722,878 |
56,825,444 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
increases expression |
ISO |
6 |
42,350,541 |
42,356,748 |
RGD:6480464 |
CTD |
| G |
Sbp |
spermine binding protein |
|
decreases expression |
EXP |
10 |
13,183,508 |
13,186,889 |
RGD:6480464 |
CTD |
| G |
Scgb1d2 |
secretoglobin, family 1D, member 2 |
|
decreases expression |
EXP |
1 |
212,016,491 |
212,019,480 |
RGD:6480464 |
CTD |
| G |
Scgb2a2 |
secretoglobin, family 2A, member 2 |
|
decreases expression |
EXP |
1 |
212,162,326 |
212,165,105 |
RGD:6480464 |
CTD |
| G |
Sele |
selectin E |
|
multiple interactions |
ISO |
13 |
79,813,455 |
79,822,845 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
decreases expression |
ISO |
2 |
52,451,883 |
52,462,263 |
RGD:6480464 |
CTD |
| G |
Skap2 |
src kinase associated phosphoprotein 2 |
|
decreases expression |
ISO |
4 |
80,149,846 |
80,300,111 |
RGD:6480464 |
CTD |
| G |
Smad3 |
SMAD family member 3 |
|
increases expression |
ISO |
8 |
67,803,909 |
67,952,056 |
RGD:6480464 |
CTD |
| G |
Smc1a |
structural maintenance of chromosomes 1A |
|
decreases expression |
ISO |
X |
41,503,393 |
41,547,830 |
RGD:6480464 |
CTD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
decreases expression |
EXP |
17 |
3,845,190 |
3,879,165 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases expression |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
decreases expression |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
|
decreases expression |
ISO |
4 |
28,807,080 |
28,811,502 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tlr2 |
toll-like receptor 2 |
|
multiple interactions |
ISO |
2 |
175,607,990 |
175,613,992 |
RGD:6480464 |
CTD |
| G |
Tlr4 |
toll-like receptor 4 |
|
multiple interactions |
ISO |
5 |
83,564,100 |
83,577,735 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcp |
valosin-containing protein |
|
increases expression |
ISO |
5 |
59,472,100 |
59,491,508 |
RGD:6480464 |
CTD |
| G |
Wrb |
tryptophan rich basic protein |
|
decreases expression |
ISO |
11 |
36,453,285 |
36,467,217 |
RGD:6480464 |
CTD |
zeaxanthin
|
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
multiple interactions |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
affects metabolic processing |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
increases metabolic processing |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Bco2 |
beta-carotene oxygenase 2 |
|
increases expression |
ISO |
8 |
53,892,017 |
53,917,522 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
affects binding |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
affects binding |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
Term paths to the root
|